M
M. Pera
Researcher at Pompeu Fabra University
Publications - 5
Citations - 1063
M. Pera is an academic researcher from Pompeu Fabra University. The author has contributed to research in topics: Cancer & Esophageal cancer. The author has an hindex of 5, co-authored 5 publications receiving 743 citations.
Papers
More filters
Journal ArticleDOI
International consensus on standardization of data collection for complications associated with esophagectomy: Esophagectomy Complications Consensus Group (ECCG)
Donald E. Low,Derek Alderson,Ivan Cecconello,Andrew C. Chang,Gail Darling,Xavier Benoit D’Journo,S. Michael Griffin,Arnulf H. Hölscher,Wayne L. Hofstetter,Blair A. Jobe,Yuko Kitagawa,John C. Kucharczuk,Simon Law,Toni Lerut,Nick Maynard,M. Pera,Jeffrey H. Peters,C S Pramesh,John V. Reynolds,B. Mark Smithers,J. Jan B. van Lanschot +20 more
TL;DR: The proposed system for defining and recording perioperative complications associated with esophagectomy provides an infrastructure to standardize international data collection and facilitate future comparative studies and quality improvement projects.
Journal ArticleDOI
Worldwide esophageal cancer collaboration: clinical staging data
Thomas W. Rice,Carolyn Apperson-Hansen,L. M. DiPaola,M. E. Semple,T. Lerut,Mark B. Orringer,Chen Lq,Wayne L. Hofstetter,B. M. Smithers,Valerie W. Rusch,B. P. L. Wijnhoven,K. N. Chen,Andrew Davies,Xavier Benoit D’Journo,Kenneth A. Kesler,James D. Luketich,Mark K. Ferguson,Jari Räsänen,R. van Hillegersberg,W Fang,L. Durand,William H. Allum,Ivan Cecconello,Robert J. Cerfolio,M. Pera,S. M. Griffin,Renate Burger,Jun-Feng Liu,Mark S. Allen,Simon Law,Thomas J. Watson,Gail Darling,Walter J. Scott,A. Duranceau,Chadrick E. Denlinger,Paul H. Schipper,Hemant Ishwaran,Eugene H. Blackstone +37 more
TL;DR: Patients with early cancers had worse survival and those with advanced cancers better survival than expected from equivalent pathologic categories based on prior WECC pathologic data, making clinically based treatment decisions difficult and pre-treatment prognostication inaccurate.
Journal ArticleDOI
Esophageal Cancer: Associations With (pN+) Lymph Node Metastases.
Thomas W. Rice,Hemant Ishwaran,Wayne L. Hofstetter,Paul H. Schipper,Kenneth A. Kesler,Simon Law,Toni Lerut,Chadrick E. Denlinger,Jarmo A. Salo,Walter J. Scott,Thomas J. Watson,Mark S. Allen,Chen Lq,Valerie W. Rusch,Robert J. Cerfolio,James D. Luketich,André Duranceau,Gail Darling,M. Pera,Carolyn Apperson-Hansen,Eugene H. Blackstone +20 more
TL;DR: In esophageal cancer, pN+, increasing number of positive nodes, and increasing pN classification are associated with deeper invading, longer, and poorly differentiated cancers, so few nodes need to be removed if the goal of lymphadenectomy is to accurately define pN+ status of such cancers.
Journal ArticleDOI
Worldwide Esophageal Cancer Collaboration: pathologic staging data.
Thomas W. Rice,Chen Lq,Wayne L. Hofstetter,B. M. Smithers,Valerie W. Rusch,B. P. L. Wijnhoven,K. L. Chen,Andrew Davies,Xavier Benoit D’Journo,Kenneth A. Kesler,James D. Luketich,Mark K. Ferguson,Jari Räsänen,R. van Hillegersberg,W Fang,L. Durand,Ivan Cecconello,William H. Allum,Robert J. Cerfolio,M. Pera,S. M. Griffin,Renate Burger,Jun-Feng Liu,Mark S. Allen,Simon Law,Thomas J. Watson,Gail Darling,Walter J. Scott,A. Duranceau,Chadrick E. Denlinger,Paul H. Schipper,T. Lerut,Mark B. Orringer,Hemant Ishwaran,Carolyn Apperson-Hansen,L. M. DiPaola,M. E. Semple,Eugene H. Blackstone +37 more
TL;DR: Detailed descriptions of patient characteristics, cancer categories, and non-risk-adjusted survival-for patients with pathologically staged cancer of the esophagus and esophagogastric junction after resection or ablation with no preoperative therapy from the Worldwide Esophageal Cancer Collaboration are reported.
Journal ArticleDOI
Worldwide Esophageal Cancer Collaboration: neoadjuvant pathologic staging data
Thomas W. Rice,T. Lerut,Mark B. Orringer,Chen Lq,Wayne L. Hofstetter,B. M. Smithers,Valerie W. Rusch,J. J. B. van Lanschot,K. N. Chen,Andrew Davies,Xavier Benoit D’Journo,Kenneth A. Kesler,James D. Luketich,Mark K. Ferguson,Jari Räsänen,R. van Hillegersberg,W Fang,L. Durand,William H. Allum,Ivan Cecconello,Robert J. Cerfolio,M. Pera,S. M. Griffin,Renate Burger,Jun-Feng Liu,Mark S. Allen,Simon Law,Thomas J. Watson,Gail Darling,Walter J. Scott,A. Duranceau,Chadrick E. Denlinger,Paul H. Schipper,Hemant Ishwaran,Carolyn Apperson-Hansen,L. M. DiPaola,M. E. Semple,Eugene H. Blackstone +37 more
TL;DR: Data-simple descriptions of patient characteristics, cancer categories, and non-risk-adjusted survival-for pathologically staged cancers after neoadjuvant therapy from the Worldwide Esophageal Cancer Collaboration will be the basis for the 8th edition cancer staging manuals following risk adjustment for patient, cancer, and treatment characteristics.